Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics

CU Correll, A Martin, C Patel, C Benson, R Goulding… - Schizophrenia, 2022 - nature.com
Clinical practice guidelines (CPGs) translate evidence into recommendations to improve
patient care and outcomes. To provide an overview of schizophrenia CPGs, we conducted a …

New and emerging treatments for schizophrenia: a narrative review of their pharmacology, efficacy and side effect profile relative to established antipsychotics

MC Lobo, TS Whitehurst, SJ Kaar, OD Howes - … & Biobehavioral Reviews, 2022 - Elsevier
Schizophrenia is associated with substantial unmet needs, highlighting the necessity for
new treatments. This narrative review compares the pharmacology, clinical trial data and …

Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology

JP Rogers, MA Oldham, G Fricchione… - Journal of …, 2023 - journals.sagepub.com
The British Association for Psychopharmacology developed an evidence-based consensus
guideline on the management of catatonia. A group of international experts from a wide …

Scope, quality and inclusivity of international clinical guidelines on mental health and substance abuse in relation to dual diagnosis, social and community outcomes …

R Alsuhaibani, DC Smith, R Lowrie, S Aljhani… - BMC psychiatry, 2021 - Springer
Objective It is estimated that up to 75% of patients with severe mental illness (SMI) also have
substance use disorder (SUD). The aim of this systematic review was to explore the scope …

Antipsychotic treatment failure: a systematic review on risk factors and interventions for treatment adherence in psychosis

K El Abdellati, L De Picker, M Morrens - Frontiers in neuroscience, 2020 - frontiersin.org
Objective: Antipsychotic medication non-adherence has detrimental effects on patients'
clinical outcome. It is unclear which risk factors affect adherence most and which …

A network meta-analysis of efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia

S Dong, J Schneider-Thoma, I Bighelli, S Siafis… - European Archives of …, 2024 - Springer
Objective Clozapine is considered as the standard treatment for this subgroup, but the
evidence is not unequivocal. There are several potential alternatives being used because of …

Multigenetic Pharmacogenomics–Guided Treatment vs Treatment As Usual Among Hospitalized Men With Schizophrenia: A Randomized Clinical Trial

Z Kang, Y Qin, Y Sun, Z Lu, Y Sun, H Chen… - JAMA Network …, 2023 - jamanetwork.com
Importance Limited evidence supports multigenetic pharmacogenomics–guided treatment
(MPGT) in schizophrenia. Objective To evaluate the clinical effectiveness of MPGT in …

[HTML][HTML] Data-driven taxonomy for antipsychotic medication: a new classification system

RA McCutcheon, PJ Harrison, OD Howes… - Biological …, 2023 - Elsevier
Background Globally, there are more than 25 licensed antipsychotic medications.
Antipsychotics are commonly described as either typical or atypical, but this dichotomous …

Pathophysiology, prognosis and treatment of tardive dyskinesia

H Takeuchi, Y Mori, Y Tsutsumi - Therapeutic advances in …, 2022 - journals.sagepub.com
Tardive dyskinesia (TD), a movement disorder associated with antipsychotics, most
frequently affects the lower face and jaw muscles, but can also affect walking, breathing and …

Meta-analysis of insomnia, suicide, and psychopathology in schizophrenia

BJ Miller, WV McCall - Current opinion in psychiatry, 2023 - journals.lww.com
Meta-analysis of insomnia, suicide, and psychopathology in s... : Current Opinion in Psychiatry
Meta-analysis of insomnia, suicide, and psychopathology in schizophrenia : Current Opinion …